InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,978.00
(
-1.19%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.28
(
0.01%
)
Bitcoin
60,312.33
(
0.08%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Inoviorulez

Send PM Follow Ignore
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Inoviorulez

Re: 1~Eye~Jack!! post# 74985

Wednesday, 05/29/2013 11:54:01 AM

Wednesday, May 29, 2013 11:54:01 AM

Post# of 158400
The reason for the dilution is because the FDA has to decide whether to approve Hemaxellerate for trials. The CEO can't see the future how does he know whether or not the FDA will approve for the trials? He is not a sight seer who can see into the future.

Biotech stocks always dilute before FDA decisions because they can't predict what the FDA will do! All biotechs are like that!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up